News

ACEP Welcomes Michael Fraser, PhD as New Executive Director

ACEP Welcomes Michael Fraser, PhD as New Executive Director

Michael Fraser, PhD, Takes the Lead at ACEP

The American College of Emergency Physicians (ACEP) has recently announced a significant change in leadership, welcoming Michael Fraser, PhD, MS, CAE, as the new executive director. This transition comes at a crucial time for the organization, which is committed to empowering emergency physicians across the nation.

Fraser's Vision for Emergency Medicine

Dr. Fraser brings a wealth of experience to ACEP. He stated his honor in taking on this role, revealing insights into the dedication and passion exhibited by ACEP members. He recognizes the essential function that emergency physicians fulfill in the healthcare landscape, especially in moments of crisis.

His vision focuses on enhancing the practice of emergency medicine and advocating for the rights and needs of emergency physicians. Fraser aims to utilize his extensive background in medical organizations and public health to champion these efforts.

Previous Leadership Experience

Prior to his appointment at ACEP, Dr. Fraser served as the chief executive officer (CEO) of the College of American Pathologists. His leadership skills were further honed during his tenure as CEO of the Association of State and Territorial Health Officials. His dynamic leadership is complemented by his experience as executive vice president and CEO of the Pennsylvania Medical Society.

Academic and Professional Credentials

Dr. Fraser is not only a leader but also an accomplished academic. He has authored over 40 peer-reviewed publications and contributed to numerous books, showcasing his expertise in public health and management. His academic appointments at George Mason University’s College of Public Health highlight his commitment to education and research in health administration.

A Pivotal Role for Emergency Physicians

As he steps into his new role, Dr. Fraser acknowledges the challenging landscape that emergency physicians face today. He emphasizes the importance of addressing threats to their autonomy, advocating for a system that minimizes barriers to their mission of providing care whenever it is needed.

Support from the ACEP Community

ACEP president, Dr. Alison Haddock, expressed confidence in Dr. Fraser's leadership, stating that his combination of public health experience and management acumen positions the organization for future success. The support from the ACEP community plays a vital role in amplifying the voices of emergency physicians throughout their careers.

The Importance of Advocacy and Education

ACEP continues to serve as the national medical society for emergency medicine, representing around 40,000 members and directly impacting over 150 million patients each year. The organization prioritizes education, research, and advocacy, striving to advance emergency care standards and promote the profession.

Looking Forward

As Dr. Fraser embarks on this journey with ACEP, the focus will remain on improving emergency care and elevating the profession’s profile. His leadership promises to bring new initiatives aimed at supporting emergency physicians in their critical roles in the healthcare system.

Frequently Asked Questions

Who is Michael Fraser?

Michael Fraser, PhD, MS, CAE, is the new executive director of the American College of Emergency Physicians.

What experience does Dr. Fraser have?

Dr. Fraser has notable experience, including past tenure as CEO of the College of American Pathologists and extensive leadership in various health organizations.

What are Dr. Fraser's goals at ACEP?

His goals include advocating for emergency physicians and enhancing the practice of emergency medicine on a national level.

How does ACEP support its members?

ACEP advocates for emergency medicine, provides education and resources, and enhances public awareness of emergency care issues.

Why is the leadership transition important?

This leadership change comes at a pivotal time for emergency medicine, addressing current challenges and reinforcing advocacy efforts for the specialty.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 125

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 116

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 221

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 137

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 167

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 253

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 44

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

We Energies Recognized for Exceptional Reliability Standards

Updated Category News Views 172

We Energies Celebrated for Excellence in Reliability MILWAUKEE / We Energies has recently been honored with the esteemed 2025 ReliabilityOne® Award, recognizing its superior performance in delivering reliable electric service. This accolade is a testament to the dedication and expertise of its workforce, as well as the strategic investments the company has made to...

Continue Reading
MicroStrategy Options Activity: Insights and Market Trends

Updated Category News Views 59

What Recent Options Activity Says About MicroStrategy Options flow often hints at how the crowd feels before price moves show it. Lately, the tone around MicroStrategy (MSTR) has leaned bearish, a point worth noting if you’re weighing your own trades. The signal isn’t subtle: activity has picked up sharply, and that surge alone can draw in traders who watch sentiment...

Continue Reading
Viactiv Expands Wellness Line with New Chews and Powder

Updated Category News Views 16

Viactiv Expands Beyond Calcium Forget just bone health; Viactiv is stepping up its game. They've gone beyond their trusty calcium chews with something new that targets women’s wellness in a broader sense. Meet the newcomers: Viactiv® CoQ10 CARDIO Complete Soft Chews and Viactiv® Magnesium Glycinate Powder. Ain't that a mouthful? But seriously, these are designed for...

Continue Reading
Rathbones Group Plc's Significant Position in Warpaint London

Updated Category News Views 107

Key Disclosure of Rathbones Group Plc In the financial landscape, transparency is of utmost importance, especially when significant interests in securities come to light. Rathbones Group Plc has provided a crucial disclosure as they maintain an interest in relevant securities of Warpaint London Plc, representing over 1% of their shares. This type of disclosure aligns with...

Continue Reading
Insights into Tryg A/S Q4 2024 Performance and Expectations

Updated Category News Views 260

Overview of Tryg A/S Q4 2024 Newsletter As the end of the year approaches, Tryg A/S is gearing up for a busy period of financial disclosures and investor engagement. In the week commencing mid-December, Tryg will conduct several pre-close analyst calls and meetings. This initiative is designed to prepare stakeholders ahead of the crucial Q4 2024 results release, which is...

Continue Reading